货号: CL-0492
Price: ¥1600 ¥1600
生长培养基: MEM(含NEAA)[PM150410]+10% FBS[164210]+1% P/S[PB180120]
产品信息
产品名称 | MNNG/HOS Cl #5 [R-1059-D](人骨肉瘤细胞) |
别称 | MNNG/HOS; MNNG-HOS; HOS-MNNG; MNNGHOS; MNNG-HOS (Cl#5) ; MNNG/HOS Clone F-5; MNNG; R-1059-D; TE85; TE-85; HOS-TE85; Hos TE-85; HOS TE 85; HOS TE85; HOS (TE85) ; HOS (TE85) ; HOS (TE85, Clone F5) ; MNNG-HOS (TE 85, clone F-5) ; HOS-Te85; TE 85.T; TE 85 ClF-5; TE-85 clone 5 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:MEM(含NEAA)[PM150410]+10% FBS[164210]+1% P/S[PB180120] 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:2-1:4 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | MNNG/HOS Cl #5 [R-1059-D]细胞是HOS经0.01 mcg/mL MNNG(一种致癌的亚硝胺)转化而来。MNNG/HOS Cl #5 [R-1059-D]细胞饱和浓度高,在软琼脂中的克隆形成率高,并能在裸鼠中成瘤。 |
年龄(性别) | 13Y Female |
组织来源 | 骨;骨肉瘤 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肉瘤细胞 |
生物安全等级 | BSL-1 |
STR位点信息
STR鉴定图
-
Disulfidptosis-related PABPC3 promotes tumor progression and inhibits immune activity in osteosarcoma(2023)
作者:Yangbo Cao, Song Wu, Yishan Gu, Yung Hou Wong, Yanbin Shi, Lina Zhang
期刊:JOURNAL OF GENE MEDICINE
DOI:10.1002/jgm.3641
影响因子:3.5
引用产品: U-2 OS [U2OS] 细胞, MNNG/HOS Cl #5 [R-1059-D] 细胞, McCoy's 5A 培养基, MEM 培养基
-
Diverse cell death patterns-related signature for predicting prognosis and drug sensitivity of osteosarcoma patients(2023)
作者:Yanbin Shi, Song Wu, Xiaolin Zhang, Yangbo Cao, Lina Zhang
期刊:JOURNAL OF GENE MEDICINE
DOI:10.1002/jgm.3613
影响因子:3.5
引用产品: U-2 OS [U2OS] 细胞, MNNG/HOS Cl #5 [R-1059-D] 细胞, McCoy's 5A 培养基, MEM 培养基
-
Engineered biomimetic nanoreactor for synergistic photodynamic-chemotherapy against hypoxic tumor(2022)
作者:Haoyu Guo, Lutong Wang, Wei Wu, Mingke Guo, Lingkai Yang, Zhenhao Zhang, Li Cao, Feifei Pu, Xin Huang, Zengwu Shao
期刊:JOURNAL OF CONTROLLED RELEASE
DOI:10.1016/j.jconrel.2022.09.020
影响因子:11.5
引用产品: MNNG/HOS Cl #5 [R-1059-D] 细胞, U-2 OS [U2OS] 细胞, 人脐静脉内皮细胞, RAW 264.7 细胞
-
Chitosan based photothermal scaffold fighting against bone tumor-related complications: Recurrence, infection, and defects(2022)
作者:Yao Zhao, Xu Peng, Xiaoyang Xu, Mingzhen Wu, Fan Sun, Qiangwei Xin, Hongbo Zhang, Liangrui Zuo, Yilin Cao, Yuhang Xia, Jun Luo, Chunmei Ding, Jianshu Li
期刊:CARBOHYDRATE POLYMERS
DOI:10.1016/j.carbpol.2022.120264
影响因子:10.7
-
A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma.(2022)
作者:Xinxing Wang, Guang Xia, Shilang Xiao, Song Wu, Lina Zhang, Junjie Huang, Wenxiu Zhang, Xu Cao
期刊:Frontiers in Oncology
影响因子:5.7
引用产品: U-2 OS [U2OS] 细胞, MNNG/HOS Cl #5 [R-1059-D] 细胞, McCoy's 5A 培养基, MEM 培养基
-
A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma(2022)
作者:Lina Zhang, Song Wu, Junjie Huang, Yanbin Shi, Yuesong Yin, Xu Cao
期刊:Frontiers in Oncology
影响因子:5.7
引用产品: MEM 培养基, MNNG/HOS Cl #5 [R-1059-D] 细胞, U-2 OS [U2OS] 细胞, McCoy's 5A 培养基
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图